局部浸润镇痛中使用高剂量复方倍他米松不增加假体周围感染治疗后的再感染率
该回顾性研究纳入2010至2021年299例单期翻修假体周围感染病例,其中127例接受含高剂量复方倍他米松的局部浸润镇痛(CB组),172例未接受(非CB组)。结果表明两组再感染率无显著差异(9.3% vs 8.7%,P=0.85),CB组术后恶心呕吐发生率更低,术后48小时内静息和运动VAS评分更低,术后72小时内额外阿片类药物需求更少。
要点
- 高剂量复方倍他米松局部浸润镇痛不增加假体周围感染单期翻修术后再感染率(9.3% vs 8.7%,P=0.85)。
- CB组术后恶心呕吐发生率显著低于非CB组(P<0.05)。
- CB组术后48小时内静息和运动VAS评分均更低,膝关节运动VAS评分在72小时仍更低(P<0.001)。
核心结论
- 含高剂量复方倍他米松的局部浸润镇痛可减少单期翻修术后疼痛、阿片类药物消耗和术后恶心呕吐发生率,且不影响再感染率和其他并发症率。
研究设计与样本
- 回顾性研究,纳入2010至2021年299例单期翻修假体周围感染病例,其中127例接受含高剂量复方倍他米松的局部浸润镇痛(CB组),172例未接受(非CB组)。
主要发现
- 至少2年随访期间,非CB组与CB组再感染率分别为9.3%和8.7%,无显著差异(P=0.85)。
- 髋关节假体周围感染亚组再感染率非CB组8.4% vs CB组4.5%(P=0.51),膝关节亚组非CB组10.4% vs CB组13.3%(P=0.60)。
- 高剂量CB既不是再感染的独立危险因素(P>0.05;95%CI包含1),也与再感染发生无关(P>0.05)。
- CB组术后恶心呕吐发生率显著更低(P<0.05);术后48小时内CB组静息和运动VAS平均评分均更低(P<0.05),膝关节运动VAS评分在术后72小时仍更低(P<0.001)。
- 术后72小时内CB组额外阿片类药物需求少于非CB组(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cocktails containing glucocorticoids for local infiltration analgesia (LIA) are highly advocated and effective in managing pain in total joint arthroplasty (TJA). However, it remains ambiguous whether this protocol maintains its safety and efficacy in the treatment of periprosthetic joint infection (PJI), a devastating complication of TJA. METHODS: A retrospective study was conducted on 299 single-stage revision cases for PJI spanning the years 2010 to 2021. Of these, 127 received LIAs containing high-dose compound betamethasone (CB) were termed the CB group, and the other 172 were termed the non-CB group. The rates of re-infection and other postoperative complications, along with postoperative visual analog scale (VAS) scores, and opioid consumption were compared. RESULTS: During minimum 2-year follow-up, there was no significant difference in the re-infection rate between the non-CB and CB groups (9.3 versus 8.7%; P = 0.85), consistent within the subsets of hip (8.4 versus 4.5%; P = 0.51) and knee (10.4 versus 13.3%; P = 0.60) PJIs individually. The administration of high-dose CB was neither an independent risk factor for reinfection (P > 0.05; 95% CI [confidence interval] including 1) nor was it associated with the occurrence of reinfection (P > 0.05). The incidence of postoperative nausea and vomiting (PONV) was significantly lower in the CB group (P < 0.05). In the first 48-hour postoperative period, the CB group exhibited lower mean scores in both resting and movement VAS evaluations (P < 0.05). For knees, the movement VAS scores of the CB group remained lower even at 72 hours post-surgery (P < 0.001). Furthermore, within the first 72 hours post-surgery, the CB group required less additional opioid analgesics than the non-CB group (P < 0.05). CONCLUSIONS: A LIA with a high-dose CB reduces postoperative pain, opioid consumption, and the incidence of PONV following a single-stage revision without affecting reinfection and other complication rates.
引用
- Guo X, Ji B, Zhang X, et al. High-Dose Compound Betamethasone Used in Local Infiltration Analgesia Does Not Increase Reinfection Rates Following Periprosthetic Joint Infection Treatment. J Arthroplasty. 2024. PMID: 39370016. doi:10.1016/j.arth.2024.09.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。